Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-21-000140

Options or other derivatives

  • Director acquired 3,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
El-Hibri Fuad Director 2020-07-02 Grant or award · Stock Option (right to buy) +3,571 3,571 D
Loading xslF345X03/elhibri.xml…